Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 137

1.

Minocycline and cisplatin exert synergistic growth suppression on hepatocellular carcinoma by inducing S phase arrest and apoptosis.

Liu FY, Wu YH, Zhou SJ, Deng YL, Zhang ZY, Zhang EL, Huang ZY.

Oncol Rep. 2014 Aug;32(2):835-44. doi: 10.3892/or.2014.3248. Epub 2014 Jun 12.

PMID:
24919588
2.

Inhibitory effect of oleanolic acid on hepatocellular carcinoma via ERK-p53-mediated cell cycle arrest and mitochondrial-dependent apoptosis.

Wang X, Bai H, Zhang X, Liu J, Cao P, Liao N, Zhang W, Wang Z, Hai C.

Carcinogenesis. 2013 Jun;34(6):1323-30. doi: 10.1093/carcin/bgt058. Epub 2013 Feb 12.

3.

Suppression of AKT anti-apoptotic signaling by a novel drug candidate results in growth arrest and apoptosis of hepatocellular carcinoma cells.

Cuconati A, Mills C, Goddard C, Zhang X, Yu W, Guo H, Xu X, Block TM.

PLoS One. 2013;8(1):e54595. doi: 10.1371/journal.pone.0054595. Epub 2013 Jan 23.

4.

Inhibition of Stat3 activity by YC-1 enhances chemo-sensitivity in hepatocellular carcinoma.

Lau CK, Yang ZF, Lam SP, Lam CT, Ngai P, Tam KH, Poon RT, Fan ST.

Cancer Biol Ther. 2007 Dec;6(12):1900-7. Epub 2007 Sep 1.

PMID:
18059167
5.

Sinomenine hydrochloride inhibits human hepatocellular carcinoma cell growth in vitro and in vivo: involvement of cell cycle arrest and apoptosis induction.

Lu XL, Zeng J, Chen YL, He PM, Wen MX, Ren MD, Hu YN, Lu GF, He SΧ.

Int J Oncol. 2013 Jan;42(1):229-38. doi: 10.3892/ijo.2012.1704. Epub 2012 Nov 16.

PMID:
23165705
6.

Novel synergistic antitumor effects of rapamycin with bortezomib on hepatocellular carcinoma cells and orthotopic tumor model.

Wang C, Gao D, Guo K, Kang X, Jiang K, Sun C, Li Y, Sun L, Shu H, Jin G, Sun H, Wu W, Liu Y.

BMC Cancer. 2012 May 4;12:166. doi: 10.1186/1471-2407-12-166.

7.

Aspirin enhances doxorubicin-induced apoptosis and reduces tumor growth in human hepatocellular carcinoma cells in vitro and in vivo.

Hossain MA, Kim DH, Jang JY, Kang YJ, Yoon JH, Moon JO, Chung HY, Kim GY, Choi YH, Copple BL, Kim ND.

Int J Oncol. 2012 May;40(5):1636-42. doi: 10.3892/ijo.2012.1359. Epub 2012 Feb 7.

PMID:
22322725
8.

Suberoylanilide hydroxamic acid enhances chemosensitivity to 5-fluorouracil in hepatocellular carcinoma via inhibition of thymidylate synthase.

Liao B, Liang H, Chen J, Liu Q, Zhang B, Chen X.

Tumour Biol. 2015 Dec;36(12):9347-56. doi: 10.1007/s13277-015-3497-9. Epub 2015 Jun 25.

PMID:
26108995
9.

Swainsonine inhibits growth and potentiates the cytotoxic effect of paclitaxel in hepatocellular carcinoma in vitro and in vivo.

You N, Liu W, Wang T, Ji R, Wang X, Gong Z, Dou K, Tao K.

Oncol Rep. 2012 Dec;28(6):2091-100. doi: 10.3892/or.2012.2035. Epub 2012 Sep 17.

PMID:
22993037
10.

Synergistic growth-suppressive effects of quercetin and cisplatin on HepG2 human hepatocellular carcinoma cells.

Zhao JL, Zhao J, Jiao HJ.

Appl Biochem Biotechnol. 2014 Jan;172(2):784-91.

PMID:
24122665
11.

Longikaurin A, a natural ent-kaurane, induces G2/M phase arrest via downregulation of Skp2 and apoptosis induction through ROS/JNK/c-Jun pathway in hepatocellular carcinoma cells.

Liao YJ, Bai HY, Li ZH, Zou J, Chen JW, Zheng F, Zhang JX, Mai SJ, Zeng MS, Sun HD, Pu JX, Xie D.

Cell Death Dis. 2014 Mar 20;5:e1137. doi: 10.1038/cddis.2014.66.

12.

Enhanced antitumor activity by combining an adenovirus harboring ING4 with cisplatin for hepatocarcinoma cells.

Xie Y, Sheng W, Miao J, Xiang J, Yang J.

Cancer Gene Ther. 2011 Mar;18(3):176-88. doi: 10.1038/cgt.2010.67. Epub 2010 Nov 5.

13.
14.

In vitro and in vivo anticarcinogenic effects of RNase MC2, a ribonuclease isolated from dietary bitter gourd, toward human liver cancer cells.

Fang EF, Zhang CZ, Zhang L, Fong WP, Ng TB.

Int J Biochem Cell Biol. 2012 Aug;44(8):1351-60. doi: 10.1016/j.biocel.2012.04.013. Epub 2012 Apr 24.

PMID:
22554586
15.

Characterization of 9-nitrocamptothecin liposomes: anticancer properties and mechanisms on hepatocellular carcinoma in vitro and in vivo.

Zheng S, Chang S, Lu J, Chen Z, Xie L, Nie Y, He B, Zou S, Gu Z.

PLoS One. 2011;6(6):e21064. doi: 10.1371/journal.pone.0021064. Epub 2011 Jun 9.

16.

Ethyl pyruvate inhibits proliferation and induces apoptosis of hepatocellular carcinoma via regulation of the HMGB1-RAGE and AKT pathways.

Cheng P, Dai W, Wang F, Lu J, Shen M, Chen K, Li J, Zhang Y, Wang C, Yang J, Zhu R, Zhang H, Zheng Y, Guo CY, Xu L.

Biochem Biophys Res Commun. 2014 Jan 24;443(4):1162-8. doi: 10.1016/j.bbrc.2013.12.064. Epub 2013 Dec 19.

PMID:
24361892
17.

Synergistically killing activity of aspirin and histone deacetylase inhibitor valproic acid (VPA) on hepatocellular cancer cells.

Li X, Zhu Y, He H, Lou L, Ye W, Chen Y, Wang J.

Biochem Biophys Res Commun. 2013 Jun 28;436(2):259-64. doi: 10.1016/j.bbrc.2013.05.088. Epub 2013 May 30.

PMID:
23726914
18.

Celastrol exerts synergistic effects with PHA-665752 and inhibits tumor growth of c-Met-deficient hepatocellular carcinoma in vivo.

Jiang HL, Jin JZ, Wu D, Xu D, Lin GF, Yu H, Ma DY, Liang J.

Mol Biol Rep. 2013 Jul;40(7):4203-9. doi: 10.1007/s11033-013-2501-y. Epub 2013 May 7.

PMID:
23649759
19.

GYY4137, a hydrogen sulfide (H₂S) donor, shows potent anti-hepatocellular carcinoma activity through blocking the STAT3 pathway.

Lu S, Gao Y, Huang X, Wang X.

Int J Oncol. 2014 Apr;44(4):1259-67. doi: 10.3892/ijo.2014.2305. Epub 2014 Feb 14.

PMID:
24535538
20.

A novel herbal formula induces cell cycle arrest and apoptosis in association with suppressing the PI3K/AKT pathway in human lung cancer A549 cells.

Xiong F, Jiang M, Huang Z, Chen M, Chen K, Zhou J, Yin L, Tang Y, Wang M, Ye L, Zhan Z, Duan J, Fu H, Zhang X.

Integr Cancer Ther. 2014 Mar;13(2):152-60. doi: 10.1177/1534735413503544. Epub 2013 Oct 7.

PMID:
24105357
Items per page

Supplemental Content

Write to the Help Desk